Possible Involvement of IκB Kinase 2 and MKK7 in Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor κB Ligand
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Recent studies have revealed the essential role of the receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) in osteoclast differentiation and activation. Adenovirus vector could efficiently transduce genes into RAW264.7 cells, which differentiate into osteoclast-like multinucleated cells in the presence of RANKL. The role of NF-κB and c-jun N-terminal kinase (JNK) activation in RANKL-induced osteoclast differentiation was investigated using an adenovirus vector carrying the dominant negative IκB kinase 2 gene (AxIKK2DN) or dominant negative MKK7 gene (AxMKK7DN). IKK2DN and MKK7DN overexpression in RAW cells specifically suppressed the NF-κB activation and JNK activation in response to RANKL, respectively, without affecting other signaling pathways. Either inhibition of NF-κB or JNK pathways dose-dependently inhibited osteoclast formation induced by RANKL. These results suggest that both NF-κB and JNK activation are independently required for osteoclast differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · cited 1×
“activated by proinflammatory cytokines.((47)) To specifically inhibit JNK activation in RAW cells, we used dominant negative MKK7 because MKK4 is known to activate p38 MAPK as well and, therefore, it is possible that the dominant negative mutant of MKK4 may affect the p38 activation in response to RANKL.”
BackgroundOPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 2×
“Mice deficient in RANKL showed osteopetrotic pathology caused by the lack of osteoclast differentiation((7)) and targeted disruption of RANK, the receptor of RANKL, also induced osteopetrosis in mice.”
BackgroundOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483 · cited 2×
“rosis due to the increased number and activity of osteoclasts.((11,12)) These findings indicate that RANKL and OPG”
BackgroundHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“It was reported that RAW cells express high levels of RANK and require RANKL but not M-CSF for their differentiation into osteoclast-like multinucleated cells.((45)) As shown in Figs.”
BackgroundRANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478 · cited 2×
“Mice deficient in RANKL showed osteopetrotic pathology caused by the lack of osteoclast differentiation((7)) and targeted disruption of RANK, the receptor of RANKL, also induced osteopetrosis in mice.((8,43)) In contrast, a deficiency of OPG, a specific inhibitor of RANKL, caused osteoporotic skeletal changes in mice,…”
BackgroundLi, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119 · cited 2×
“oclastogenesis on ligand binding or agonistic anti-RANK antibody stimulation.((8,13)) Like other TNFR superfamily The authors have no conflict of interest.”
BackgroundRequirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775 · cited 1×
“rosis due to the increased number and activity of osteoclasts.((11,12)) These findings indicate that RANKL and OPG”
BackgroundRANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746 · cited 2×
“oclastogenesis on ligand binding or agonistic anti-RANK antibody stimulation.((8,13)) Like other TNFR superfamily The authors have no conflict of interest.”
Background
Cited by
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420
Recent advances in osteoclast biology
Ono, T., & Nakashima, T. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1636-2 · Cited by 384
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts
Lee, Z. H., & Kim, H.-H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00695-8 · Cited by 381
Tanaka, S., Nakamura, K., Takahasi, N., & Suda, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00327.x · Cited by 320
Self-citationYoshitake, F., Itoh, S., Narita, H., Ishihara, K., & Ebisu, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m607999200 · Cited by 291
Signaling Pathways in Osteoclast Differentiation
Kim, J. H., & Kim, N. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.1.12 · Cited by 262
Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606656200 · Cited by 236
Self-citationRANK‐mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis
Gohda, J., Akiyama, T., Koga, T., Takayanagi, H., Tanaka, S., & Inoue, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600564 · Cited by 226
“…cells is abrogated in the absence of TRAF6 (Kobayashi et al, 2001), consistent with previous findings that NF-kB and MAPKs play crucial roles in osteoclastogenesis (Franzoso et al, 1997; Iotsova et al, 1997; Matsumoto et al, 2000; David et al, 2002; Yamamoto et al, 2002; Ikeda et al, 2004).”
ResultSelf-citationYu, X., Huang, Y., Collin-Osdoby, P., & Osdoby, P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040910 · Cited by 219
“, in CCR expression profiles or signaling responses), especially because the ability of different RAW cell lines to form OCs in response to RANKL alone varies widely.((40,60,61)) Because the issue of which CCR primarily transduces the osteoclastogenic (or chemotactic) effects of MIP-1 is currently unclear,((50,54,55))…”
BackgroundSignaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
Soltanoff, C. S., Yang, S., Chen, W., & Li, Y.-P. (2009) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.10 · Cited by 197
Ahn, K. S., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23745 · Cited by 109
Fabre, C., Mimura, N., Bobb, K., Kong, S.-Y., Gorgun, G., Cirstea, D., Hu, Y., Minami, J., Ohguchi, H., Zhang, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0779 · Cited by 82
Metadata
- Authors
- Yamamoto, A., Miyazaki, T., Kadono, Y., Takayanagi, H., Miura, T., Nishina, H., Katada, T., Wakabayashi, K., Oda, H., Nakamura, K., & Tanaka, S.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-01
- Volume
- 17
- Issue
- 4
- Pages
- 612-621
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2127743278
- Cited by
- 85
- References
- 12
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.